Martin K. Till has been named president and CEO of HNL Lab Medicine, replacing Matthew R. Sorrentino, who will retire Oct. 15.
Read More »Martin K. Till has been named president and CEO of HNL Lab Medicine, replacing Matthew R. Sorrentino, who will retire Oct. 15.
Read More »